This report analyzes the global market for Cancer Therapies in US$ Billion by the following segments: Chemotherapy, Targeted Therapy, Hormonal Therapy, and Immunotherapy. Annual forecasts are provided for the period 2006 through 2015. A six-year historic analysis is also provided for these markets. The report profiles 208 companies including many key and niche players worldwide such as Abraxis BioScience, Inc., Amgen, Inc., AstraZeneca PLC, Bayer Schering Pharma, Biogen Idec Inc., Bristol-Myers Squibb Company, Celgene Corporation, Cell Therapeutics, Inc., Cephalon, Inc., Chugai Pharmaceutical Co., Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Genentech, Inc., Genzyme, GlaxoSmithKline, Imclone Systems, Inc., Merck KGaA, Novartis AG, Ortho Biotech Products, L.P, OSI Pharmaceuticals, Inc., Pfizer, Sanofi-Aventis, Schering Plough Corporation, Seattle Genetics, Inc., Takeda Pharmaceutical Company Limited, and Wyeth. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Total Companies Profiled: 207 (including Divisions/Subsidiaries - 226) Region/Country Players The United States 137 Canada 12 Japan 8 Europe 48 France 7 Germany 5 The United Kingdom 8 Italy 1 Spain 3 Rest of Europe 24 Asia-Pacific (Excluding Japan) 14 Latin America 1 Middle East 6